Closing the loop: modelling of heart failure progression from health to end-stage using a meta-analysis of left

David R Warriner1, Alistair G Brown2, Susheel Varma2

  • 1Medical Physics Group, Department of Cardiovascular Science, University of Sheffield, Sheffield, S10 2TN, United Kingdom; Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals, Sheffield, S5 7AU, United Kingdom.

Plos One
|December 6, 2014
PubMed

Insights

This study quantitatively models heart failure (HF) progression using left ventricular (LV) pressure-volume loops. Elastance emerged as a key parameter for staging HF, offering objective measures beyond current guidelines.

Area of Science:

  • Cardiovascular Physiology
  • Biomedical Engineering
  • Heart Failure Research

Background:

  • Current American Heart Association (AHA)/American College of Cardiology (ACC) heart failure (HF) guidelines lack objective measures for staging.
  • Left ventricular (LV) pressure-volume (PV) loop data offers a potential avenue for quantitative HF assessment.
  • There is a need for precise parameters to categorize HF progression.

Purpose of the Study:

  • To quantitatively demonstrate HF progression through AHA/ACC stages using a meta-analysis of LV PV loop data.
  • To develop stage-specific HF models based on LV PV loop data.
  • To identify objective parameters for HF classification.

Main Methods:

  • Conducted a meta-analysis of 31 studies, extracting PV data from over 200 patients in various HF stages.
  • Utilized digitizing software to extract and analyze raw pressure and volume data.
  • Employed a 2-element lumped parameter model to represent mean LV PV loops and calculated elastance (Emax).

Main Results:

  • Meta-analysis revealed decreased stroke volume (SV) and ejection fraction (EF%) with increased LV volumes as HF progressed.
  • The lumped parameter model showed a close fit between mean PV loops across HF stages.
  • LV elastance (Emax) was the sole statistically significant and consistent parameter differentiating HF stages.

Conclusions:

  • Developed the first visual and quantitative representation of AHA/ACC stages of LVSD-HF.
  • Demonstrated that load-independent parameters like elastance can objectively categorize and model HF.
  • Established novel physiological parameters, including LV elastance, for each HF stage, identifying it as the primary determinant of HF severity in lumped parameter models.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
649
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
594